A Rollover Study of CC-122

NCT05688475 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin Lymphoma

Interventions

DRUG: CC-122
DRUG: Dexamethasone

Sponsor

Bristol-Myers Squibb